Results 111 to 120 of about 64,974 (298)

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen   +7 more
wiley   +1 more source

Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus

open access: yes, 2010
Pamela KushnerUniversity of California, Irvine College of Medicine, California, USAAbstract: Hypoglycemia is a major barrier to achieving glycemic goals in patients with diabetes.
Kushner P, Pamela Kushner
core  

Tigecycline-induced sustaining and severe hypoglycemia: a case report

open access: yes, 2018
We describe a case of sustaining and severe hypoglycemia in a patient treated with tigecycline for pneumonia infected with MDR klebsiella. 50% glucose supplement through femoral vein was required for over 20 hours to maintain the blood glucose. The first
Chen, Y (via Mendeley Data)
core   +1 more source

Inherited metabolic epilepsies–established diseases, new approaches

open access: yesEpilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

Mitigating Severe Hypoglycemia in Users of Advanced Diabetes Technologies:Impaired Awareness of Hypoglycemia and Unhelpful Hypoglycemia Beliefs as Targets for Interventions [PDF]

open access: yes
Objective: A subgroup analysis of the Hypoglycemia Awareness Restoration Programme for people with type 1 diabetes and problematic hypoglycemia persisting despite optimized care (HARPdoc) trial was conducted to explore the impact of Blood Glucose ...
Heller, Simon   +8 more
core   +1 more source

New insights into epileptic spasm generation and treatment from the TTX animal model

open access: yesEpilepsia Open, EarlyView.
Abstract Currently, we have an incomplete understanding of the mechanisms underlying infantile epileptic spasms syndrome (IESS). However, over the past decade, significant efforts have been made to develop IESS animal models to provide much‐needed mechanistic information for therapy development.
John W. Swann   +2 more
wiley   +1 more source

Neonatal seizures: Advances in diagnosis and management

open access: yesEpilepsia Open, EarlyView.
Abstract The International League Against Epilepsy (ILAE) created the ILAE Neonatal Task Force that classified neonatal seizures, defined neonatal epilepsy syndromes, and specified treatment guidelines. These frameworks, in addition to improved access to genetic testing and other recent advances, have revolutionized the diagnosis and management of ...
Elissa G. Yozawitz   +2 more
wiley   +1 more source

Real‐world‐data for phenotypes and genotypes of rare monogenic genetic epilepsies and genes of uncertain significance for epilepsy

open access: yesEpilepsia Open, EarlyView.
Abstract Objectives The objectives of this study were to develop a real‐world‐data (RWD) database for patients with epilepsy to provide further real‐world‐evidence (RWE) for monogenic genetic epilepsies; to assess the usefulness of a diagnostic algorithm in epilepsy; and to examine protein 3D structures using in silico tools to predict variant ...
Haley Morris   +4 more
wiley   +1 more source

Ketogenic diet therapy for children with super‐refractory status epilepticus in intensive care: International clinical practice recommendations

open access: yesEpilepsia Open, EarlyView.
Abstract Objective We aimed to create practical recommendations to support healthcare teams starting ketogenic diet therapy (KDT) for children with super‐refractory status epilepticus in intensive care settings. Methods A literature review was conducted to extract published data on patient selection, diet prescription, diet initiation, monitoring, fine‐
Robyn Blackford   +20 more
wiley   +1 more source

ดาสิกลูคากอนและภาวะน้ำตาลในเลือดต่ำขั้นรุนแรง Dasiglucagon and Severe Hypoglycemia

open access: yes
H บทคัดย่อ ภาวะน้ำตาลในเลือดต่ำขั้นรุนแรงเป็นอาการที่ควรเฝ้าระวังและให้การรักษาอย่างทันท่วงทีเพราะอาจทำให้เสียชีวิตได้ เกิดมากในผู้ป่วยโรคเบาหวานที่รักษาด้วยยาลดระดับน้ำตาลในเลือดหรืออินซูลิน ผู้ป่วยที่เกิดภาวะน้ำตาลในเลือดต่ำขั้นรุนแรงอาจมีข้อจำก ...
Jirakriangkai, Surinee, Khamlee, Piroon
core  

Home - About - Disclaimer - Privacy